$0.1563
-0.0047-2.92%
AIM ImmunoTech (AIM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.12 | — | $-1.08 | $-0.98 |
| Actual | $-0.43 | $-0.69 | $-1.44 | $-1.57 |
| Surprise | -258.3% | — | -33.3% | -60.2% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $26000 | $22000 | $21000 | $26000 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.09 | $-0.09 | $-0.10 |
| Revenue | |||
| Consensus | — | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $-0.43 | $-0.12 | -258.3 % |
| Q4 | Mar 27, 2026 | $-1.44 | $-1.08 | -33.3 % |
| Q3 | Nov 18, 2025 | $-1.57 | $-0.98 | -60.2 % |
| Q2 | Aug 14, 2025 | $-3.68 | $-8.00 | 54.0 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 14, 2025 | $25.00K | $100.00K | -75.0 % |
| Q1 | May 15, 2025 | $16.00K | $100.00K | -84.0 % |
| Q4 | Mar 27, 2025 | $45.00K | $45.00K | 0.00 % |
| Q3 | Nov 15, 2024 | $35.00K | $11.67K | 199.9 % |